Clare Murphy, Director of External Affairs at bpas, said:
“We absolutely support this sensible, evidence-based call from the RCOG. Women can safely use both medications for early medical abortion at home following a consultation with a healthcare professional. Telemedical services that enable women to access care without physically attending a clinic will particularly benefit women who struggle to obtain the help they need. Many women live considerable distances from clinics and can find it challenging to travel to appointments, while women in abusive relationships who cannot easily leave their homes in secrecy will also benefit from being able to seek the help they need in confidence. We agree with the RCOG that abortion needs to be decriminalised so we can deliver the most effective woman-centred care possible in line with the highest clinical standards.”
For more information, please call 07788 725 185 or email email@example.com
The RCOG’s “Better for Women” report can be read here.
bpas is a charity which sees more than 80,000 women a year for reproductive healthcare services including pregnancy counselling, abortion care, miscarriage management and contraception, at clinics across the UK. It supports and advocates for reproductive choice. BPAS also runs the Centre for Reproductive Research and Communication, which seeks to develop and deliver a research agenda that furthers women’s access to evidence-based reproductive healthcare, driven by an understanding of women’s perspectives and needs. You can find out more here: https://www.bpas.org/get-involved/centre-for-reproductive-research-communication/